Allergy and Immunology · Flint, MI
NPI
1336101443
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5155 Norko Dr
Flint, MI, 48507
Phone (810) 720-6700
Groups this clinician bills Medicare through
Medicare paid, 2024
$185K
7,143 services
Medicare patients, 2024
299
Average age 69
Drug cost, 2024
$2.5M
4,681 prescriptions
Company payments, 2025
$3,096
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Suresh Anne was code 95004 (test - miscellaneous), 1,370 times for 33 patients. In total Suresh Anne billed 7,143 services in 39 codes, and Medicare paid $185K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,370 | 33 | $2.57 | $3,523 |
| 95165 Treatment - Miscellaneous | Office | 814 | 37 | $9.96 | $8,105 |
| 95115 Treatment - Miscellaneous | Office | 400 | 34 | $6.85 | $2,741 |
| 99213 Office E&M - Established | Office | 356 | 180 | $60.64 | $22K |
| 95117 Treatment - Miscellaneous | Office | 237 | 24 | $7.51 | $1,780 |
| 99214 Office E&M - Established | Office | 90 | 65 | $85.31 | $7,677 |
| 96372 Injection Administration | Office | 79 | 15 | $9.70 | $766 |
| 99203 Office E&M - New | Office | 62 | 62 | $69.90 | $4,334 |
| G0008 Administration of influenza virus vaccine | Office | 22 | 22 | $31.20 | $687 |
| 99204 Office E&M - New | Office | 22 | 22 | $107.30 | $2,361 |
| 90662 Vaccine Product | Office | 17 | 17 | $79.89 | $1,358 |
By year: 2022 $175K for 6,663 services; 2023 $176K for 6,748 services; 2024 $185K for 7,143 services.
Medicare prescription drug claims, 2024
In 2024, the drug Suresh Anne prescribed most often to Medicare patients was Montelukast Sodium, with 1,015 prescriptions and refills. In total Suresh Anne wrote 4,681 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,015 | 2,050 | 286 | $14K |
| Famotidine Generic | 385 | 669 | 111 | $3,776 |
| Hydroxyzine Hcl Generic | 227 | 336 | 79 | $5,351 |
| Ipratropium Bromide Generic | 208 | 254 | 66 | $9,983 |
| Prednisone Generic | 208 | 210 | 141 | $498 |
| Azithromycin Generic | 199 | 211 | 123 | $1,160 |
| Doxycycline Hyclate Generic | 197 | 211 | 142 | $2,733 |
| Dupixent Pen Dupilumab | 145 | 145 | 13 | $528K |
| Pantoprazole Sodium Generic | 135 | 259 | 47 | $1,825 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 122 | 164 | 33 | $96K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 118 | 118 | 86 | $1,753 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 118 | 222 | 29 | $26K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 88 | 119 | 39 | $3,196 |
| Fluticasone Propionate Generic | 75 | 145 | 26 | $1,904 |
| Triamcinolone Acetonide Generic | 73 | 88 | 46 | $922 |
Brand drugs: - claims; generic drugs: 3,694 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Suresh Anne $3,096 ($3,096 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $532.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 19 | $532 |
| GlaxoSmithKline, LLC. GSK | 31 | $460 |
| CSL Behring CSL.AX | 15 | $381 |
| Genzyme Corporation SNY | 12 | $319 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $264 |
| Amgen Inc. AMGN | 13 | $249 |
| Pfizer Inc. PFE | 8 | $151 |
| Ionis Pharmaceuticals, Inc. IONS | 4 | $122 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $97.63 |
| Pharming Healthcare, Inc. | 4 | $95.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.